29 March 2019 - There is no established methodology to assess the feasibility of medicine price data sources. 

Against this backdrop, a framework to guide the selection of most appropriate price data sources for pharmacoeconomic research has been developed.

According to the developed framework (called Re-ADAPT), a medicine price data source should meet the following criteria: reliability and sustainability; accessibility at a cost that users can afford; provision of medicine price information at the date(s) required; information for the defined geographic area, or at least in a representative way; coverage of the pharmaceuticals and at the price type(s) required.

Read International Journal of Technology Assessment in Health Care article